期刊文献+

乙型肝炎病毒X蛋白通过降低P4启动子甲基化水平上调人IGF-Ⅱ基因的转录 被引量:2

HBx reduces methylation level of P4 promoter and up-regulates human IGF-Ⅱ gene transcription
下载PDF
导出
摘要 目的:构建稳定表达乙型肝炎病毒X蛋白(HBx)的肝癌细胞株HepG2-HBx,探讨HBx对胰岛素样生长因子Ⅱ(IGF-Ⅱ)基因P4启动子甲基化水平及转录表达的影响。方法:应用基因重组技术,构建含HBx基因的重组逆转录病毒载体pBABE-puro-HBx,采用磷酸钙共沉淀法将其转染293FT包装细胞产生逆转录病毒,感染HepG2肝癌细胞,采用嘌呤霉素进行阳性克隆筛选,Western blotting鉴定表达HBx蛋白的肝癌细胞株HepG2-HBx。采用亚硫酸氢盐测序法及实时荧光定量RT-PCR检测HepG2-HBx细胞中P4启动子甲基化水平及P4mRNA表达水平变化。进一步将体外甲基化的人IGF-Ⅱ基因P4启动子驱动的荧光素酶报告载体pGL3-P4及含HBx基因的pCMV-tag2B-X质粒共转染HepG2肝癌细胞,采用亚硫酸氢盐测序法及双萤光素酶实验检测pGL3-P4载体上P4启动子甲基化水平及转录调控活性变化。结果:(1)经Western blotting鉴定,成功构建了稳定表达HBx蛋白的肝癌细胞株HepG2-HBx;(2)表达HBx蛋白的HepG2-HBx细胞中P4启动子甲基化CpG位点的比例(9.0%)明显低于对照细胞HepG2-control(25.0%)(P<0.01),而其P4 mRNA表达水平则为对照细胞HepG2-control的2.8倍;(3)共转染pCMV-tag2B-X质粒的HepG2细胞中pGL3-P4载体上P4启动子甲基化CpG位点的比例(60.8%)明显低于共转染对照质粒pCMV-tag2B的HepG2细胞(84.1%)(P<0.01),而前者P4启动子相对萤光素酶活性(14.12±0.89)则明显高于后者(4.61±0.76)(P<0.01)。结论:HBx蛋白可降低IGF-Ⅱ基因P4启动子甲基化水平,进而上调其转录表达。 AIM:To establish HepG2-HBx cell line stably expressing hepatitis B virus X protein(HBx) and to investigate the effect of HBx on the methylation status and transcription activity of human insulin-like growth factor II(IGF-II) gene P4 promoter. METHODS:HBx gene was cloned into the pBABE-puro retrovirus vector to construct recombinant plasmid pBABE-puro-HBx. The latter was transfected into 293FT package cells to generate retrovirus-pBABE-puro-HBx. HepG2 cells were infected with the virus suspension and the resistant cell clones were selected by puromycin. HBx expression in the HepG2-HBx cells was analyzed by Western blotting. P4 promoter methylation status and P4 mRNA expression in HepG2-HBx cells and HepG2-control cells were detected by bisulfite sequencing and real-time fluorescence quantitative RT-PCR, respectively. Furthermore, in vitro methylated pGL3-P4 vector driven by P4 promoter of human IGF-II gene was co-transfected into HepG2 cells with pCMV-tag2B-X plasmid carrying HBx gene or control empty plasmid pCMV-tag2B, and the methylation status and transcription activity of P4 promoter in pGL3-P4 vector were analyzed by bisulfite sequencing and dual-luciferase reporter assay system, respectively. RESULTS:HepG2-HBx cell line stably expressing HBx was successfully constructed. The percentage of methylated CpG dinucleotides in P4 promoter was lower in HepG2-HBx cells(9.0%) than that in HepG2-control cells(25.0%)(P〈0.01), and P4 mRNA expression level of the former was 2.8 times higher than that of the latter. The percentage of methylated CpG dinucleotides in P4 promoter at pGL3-P4 vector was lower in the HepG2 cells co-transfected with pCMV-tag2B-X(60.8%) than that in the HepG2 cells co-transfected with control empty plasmid pCMV-tag2B(84.1%)(P〈0.01), and the relative luciferase activity of the former(14.12?0.89) was higher than that of the latter(4.61?0.76)(P〈0.01). CONCLUSION:HBx may reduce the methylation level of P4 promoter and up-regulates human IGF-II gene transcription.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2012年第9期1633-1638,共6页 Chinese Journal of Pathophysiology
基金 广东省自然科学基金资助项目(No.9151008901000001) 广东省医学科学技术研究基金资助项目(No.A2009367) 中央高校基本科研业务费专项资金资助(No.11610407)
关键词 乙型肝炎病毒X蛋白 胰岛素样生长因子Ⅱ 启动子 DNA甲基化 Hepatitis B virus X protein Insulin-like growth factor II Promoters DNA methylation
  • 相关文献

参考文献1

二级参考文献2

共引文献39

同被引文献22

  • 1Abnormal expression of insulin-like growth factor-Ⅱ and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development[J].Hepatobiliary & Pancreatic Diseases International,2008,7(4):406-411. 被引量:16
  • 2Zhi-Zhen Dong,Deng-Fu Yao,Deng-Bing Yao,Xin-Hua Wu,Wei Wu,Li-Wei Qiu,Dao-Rong Jiang,Jian-Hua Zhu,Xian-Yong Meng.Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(30):4655-4660. 被引量:45
  • 3高月求,孙学华,章晓鹰,王灵台.乙肝病毒蛋白对慢性乙型肝炎患者PBMCs功能的影响[J].中国病理生理杂志,2007,23(6):1161-1163. 被引量:6
  • 4Ni YH, Huang LM, Chang MH, et al. Two decades of u- niversal hepatitis B vaccination in taiwan: impact and im- plication for future strategies [ J ]. Gastroenterology,2007, 132(4) : 1287-1293.
  • 5Clements CJ, Coghlan B, Creati M, et al. Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization.'? [ J]. Bull World Health Or- gan,2010,88(1) :66-73.
  • 6Luo Z, Li L, Ruan B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period [ J ]. Int J Infect Dis, 2012,16 ( 2 ) : e82-e88.
  • 7Su H, Zhang Y, Xu D, et al. Occult hepatitis B virus in- fection in anti-HBs-positive infants born to HBsAg-positive mothers in China[ J ]. PLoS One ,2013,8 (8) : e70768.
  • 8Hsu HY, Chang MH, Ni YH, et al. No increase in preva- lence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by uni- versal infant immunization [ J ]. J Infect Dis, 2010,201 (8) : 1192-1200.
  • 9Basuni AA, Butterworth L, Cooksley G, et al. Prevalence of HBsAg mutants and impact of hepatitis B infant immuni- sation in four Pacific Island countries[ J]. Vaccine ,2004,.22(21-22) :2791-2799.
  • 10Xu H, Peng M, Qing Y, et al. A Quasi species of the pre-S/S gene and mutations of enhancer II/core promoter/ pre-C in mothers and their children infected with hepatitis B virus via mother-to-infant transmission[ J]. J Infect Dis, 2006,193( 1 ) :88-97.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部